These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38304689)

  • 21. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
    Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
    BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OMICRON: Virology, immunopathogenesis, and laboratory diagnosis.
    Bazargan M; Elahi R; Esmaeilzadeh A
    J Gene Med; 2022 Jul; 24(7):e3435. PubMed ID: 35726542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City.
    Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
    J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
    Marcenac P; McCarron M; Davis W; Igboh LS; Mott JA; Lafond KE; Zhou W; Sorrells M; Charles MD; Gould P; Arriola CS; Veguilla V; Guthrie E; Dugan VG; Kondor R; Gogstad E; Uyeki TM; Olsen SJ; Emukule GO; Saha S; Greene C; Bresee JS; Barnes J; Wentworth DE; Fry AM; Jernigan DB; Azziz-Baumgartner E
    Emerg Infect Dis; 2022 Dec; 28(13):S26-S33. PubMed ID: 36502434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omicron variant evolution on vaccines and monoclonal antibodies.
    Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
    Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5.
    Hewins B; Richardson C; Rubino S; Kelvin A; Toloue Ostadgavahi A; Kelvin DJ
    J Infect Dev Ctries; 2022 Jul; 16(7):1122-1125. PubMed ID: 35905015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity.
    Pitsillou E; Yu Y; Beh RC; Liang JJ; Hung A; Karagiannis TC
    Clin Exp Med; 2023 Nov; 23(7):3277-3298. PubMed ID: 37615803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.
    Rochman ND; Faure G; Wolf YI; Freddolino PL; Zhang F; Koonin EV
    mBio; 2022 Apr; 13(2):e0013522. PubMed ID: 35289643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.
    Liu Q; Qin C; Liu M; Liu J
    Infect Dis Poverty; 2021 Nov; 10(1):132. PubMed ID: 34776011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022.
    Rzymski P; Kasianchuk N; Sikora D; Poniedziałek B
    J Med Virol; 2023 Jan; 95(1):e28131. PubMed ID: 36068643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2.
    Parums DV
    Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Navigating the Pandemic: An Exploration of Medical Practitioners' Preparedness, Concerns, Adaptations, and Practices During the COVID-19 Epidemic in India.
    Modi A; Jadhav K; Joshi KJ; Kadri AM; Naik AK
    Cureus; 2023 Nov; 15(11):e48677. PubMed ID: 38090450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan.
    Liu LT; Chiou SS; Chen PC; Chen CH; Lin PC; Tsai CY; Chuang WL; Hwang SJ; Chong IW; Tsai JJ
    Sci Rep; 2023 Oct; 13(1):16583. PubMed ID: 37789031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.